Blueshift Asset Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Blueshift Asset Management's AMGN Position: Q1 2025 in Review
Blueshift Asset Management sold out of Amgen (AMGN) in Q1 2025, closing a stake of 1,325 shares — an estimated $345K sold.
Blueshift Asset Management first reported a position in AMGN in Q4 2018 and held it in 12 quarters. The position peaked at $2.77M in Q3 2021. 2,926 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.
- Blueshift Asset Management reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
- Blueshift Asset Management sold 1,325 Amgen shares in Q1 2025, an estimated $345K.
- Blueshift Asset Management first reported a position in Amgen in Q4 2018 and held it in 12 quarters.
- Blueshift Asset Management's Amgen position peaked at $2.77M in Q3 2021.
- 2,926 funds tracked by Wall St. Rank held Amgen as of Q1 2025.
Based on Blueshift Asset Management's 13F filing for Q1 2025, filed 8 May 2025.